SCHEMBL11043557

SCHEMBL11043557

FC(Cc1c[nH]nn1)(Cc1c[nH]nn1)c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.35
PRKACA P17612 2/20 0.32
AKT1 P31749 2/20 0.32
AKT2 P31751 2/20 0.32
AKT3 Q9Y243 2/20 0.32
ROCK2 O75116 1/20 0.32
RPS6KA5 O75582 1/20 0.32
RPS6KA4 O75676 1/20 0.32
LATS1 O95835 1/20 0.32
PRKACB P22694 1/20 0.32
RPS6KB1 P23443 1/20 0.32
GRK2 P25098 1/20 0.32
RPS6KA3 P51812 1/20 0.32
PRKCD Q05655 1/20 0.32
ROCK1 Q13464 1/20 0.32
RPS6KA2 Q15349 1/20 0.32
RPS6KA1 Q15418 1/20 0.32
PKN1 Q16512 1/20 0.32
PKN2 Q16513 1/20 0.32
SGK3 Q96BR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11046890 0.92 CYP19A1 (0.36) CYP19A1PRKACAAKT1AKT2AKT3
SCHEMBL11046338 0.89 CYP19A1 (0.37) CYP19A1
SCHEMBL11050458 0.88 SLC6A2 (0.33)
SCHEMBL11045300 0.86 P2RX7 (0.33)
SCHEMBL11042268 0.86 MEN1 (0.31)
SCHEMBL11044112 0.86 LMNA (0.40)
SCHEMBL11063867 0.86
SCHEMBL11044703 0.85 AR (0.31)
SCHEMBL11042162 0.84 TOP2A (0.34) CYP19A1
SCHEMBL11043196 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0122452-A1 Triazolyl- and imidazolyl-substituted fluoroalkane derivatives, process for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-10-24 EP claimed
EP-0122452-A1 Triazolyl- and imidazolyl-substituted fluoroalkane derivatives, process for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-10-24 EP disclosed